Executive Briefing Series (formerly The Food & Drug Letter)
June 29, 2012
PDUFA Section on Drug Shortages Will Overburden FDA, Former Official Says
The finalized FDA user fee bill requires early notification on manufacturing changes that could create drug shortages, but the language is so vague that drugmakers will flood the agency with reports, causing more harm than good, a former FDA associate commissioner says.
This article is viewable by subscribers only. To view this article, please select an option below.